ISA Pharmaceuticals develops targeted, rationally designed immunotherapeutics for the treatment of cancer and persistent virus infections.
Location: Netherlands, South Holland, Oegstgeest
Employees: 11-50
Total raised: $30.782964M
Founded date: 2004
Investors 1
Date | Name | Website |
- | Aglaia Onc... | aglaia-onc... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
13.07.2021 | - | $30.782964... | - | finsmes.co... |
Mentions in press and media 4
Date | Title | Description | Source |
13.07.2021 | ISA Pharmaceuticals Closes €26M Funding Round | ISA Pharmaceuticals B.V., an Oegstgeest, The Netherlands-based clinical-stage immunotherapy company,... | finsmes.co... |
13.07.2021 | Regeneron again backs ISA Pharma's HPV program in $30M fundi... | Regeneron is once again backing ISA Pharmaceuticals' efforts to move a human papillomavirus treatmen... | fiercebiot... |
13.07.2021 | Dutch-based ISA Pharmaceuticals raises €26M to develop immun... | Netherlands-based ISA Pharmaceuticals is an immunotherapy company that develops treatments for vario... | siliconcan... |
13.07.2021 | Regeneron again backs ISA Pharma's HPV program in $30M fundi... | Regeneron is once again backing ISA Pharmaceuticals' efforts to move a human papillomavirus treatmen... | fiercebiot... |